<DOC>
	<DOCNO>NCT01333150</DOCNO>
	<brief_summary>The project 's primary purpose test hypothesis oral administration low single dose Î²-antagonist propranolol ( 40 mg ) reduce pain sensitivity patient masticatory muscle pain .</brief_summary>
	<brief_title>Effect Propranolol Autonomic Nervous System Muscle Pain</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Temporomandibular Joint Disorders</mesh_term>
	<mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Meet Research Diagnostic Criteria Temporomandibular Disorders ( RDC/TMD ) myofascial TMD diagnosis correspond group 1a 1b Characteristic Pain Intensity ( CPI ) equal 20 ( Axe II , RDC/TMD questionnaire ) Women childbearing potential must use adequate contraception Signed consent statement Other acute pain cause acute toothache pain condition investigator estimate contraindicate participation experiment Recognized exist malignancy within last 5 year Known HIV Abuse drug include alcohol Recognized Raynaud 's syndrome Former sympathectomy Known cardiovascular disease include abnormal EKG blood pressure ( ECG12 record first trial session assess physician ) Recognized lung insufficience , include bronchial asthma Known severe hepatic renal dysfunction Known diabetes mellitus Known severe depression Pregnancy ( test perform session 1 2 start session ) Fertility Treatment Lactation Postmenopausal Previous adverse reaction take betablocker , include hypersensitivity propranolol excipients Patients read understand write information Patients follow protocol Patients agree comply requirement participation study regard food intake , physical activity , etc .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Temporomandibular disorder</keyword>
	<keyword>Orofacial pain</keyword>
</DOC>